Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 1Active not recruiting 1

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2

Conditions

Sarcoma 16Osteosarcoma 10Carcinosarcoma 9Neoplasm Metastasis 8Rhabdomyosarcoma 7Neuroblastoma 7Melanoma 6Lymphoma, Non-Hodgkin 6Endometrial Neoplasms 6Wilms Tumor 5Sarcoma, Ewing 5Rhabdoid Tumor 5Ovarian Neoplasms 5Lung Neoplasms 5Liposarcoma 5Leiomyosarcoma 5Histiocytosis, Langerhans-Cell 5Hepatoblastoma 5Gliosarcoma 5Glioblastoma 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Carcinoma, Non-Small-Cell Lung 5Carcinoma, Hepatocellular 5Sarcoma, Kaposi 4Neuroectodermal Tumors, Primitive, Peripheral 4Medulloblastoma 4Histiocytoma, Malignant Fibrous 4Glioma 4Ependymoma 4

Interventions

Doxorubicin 6Ifosfamide 5Radiotherapy 4pazopanib 3cediranib 3atezolizumab 3Sunitinib 3selinexor 2perifosine 2pembrolizumab 2Trabectedin 2Specimen Handling 2Loperamide 2Gemcitabine 2Filgrastim 2Dacarbazine 2Cisplatin 2Biopsy 2Bevacizumab 2trifluridine tipiracil drug combination 1spartalizumab 1sargramostim 1romidepsin 1lentiviral minigene vaccine of COVID-19 coronavirus 1ixazomib 1indolepropanol phosphate 1futibatinib 1fludarabine 1cabozantinib 1brostallicin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sarcoma, Alveolar Soft Part × Specimen Handling × Sarcoma × Clear all
NCT03141684 2026-06-03

Testing Atezolizumab Alone or Atezolizumab Plus Bevacizumab in People With Advanced Alveolar Soft Part Sarcoma

National Cancer Institute (NCI)

Phase 2 Active not recruiting
63 enrolled 1 FDA
Sarcoma

Sarcoma, Alveolar Soft Part

NCT05333458 2026-05-13

Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, The AXIOM Trial

National Cancer Institute (NCI)

Phase 2 Recruiting
27 enrolled
Sarcoma

Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡